Home  >  Health Check  >  Covid-19 vaccines: Unknowns and dilemmas
Health Check
Covid-19 vaccines: Unknowns and dilemmas
Health Check
Nov 4, 2020

Some of the first large scale trials of Covid-19 vaccines may report results to regulators in the next few weeks. These first results will reveal how effective these vaccines are at preventing mild Covid illness but they’re unlikely to tell us how good they are at preventing serious disease and death. Should governments permit wide scale vaccination of populations based on that level of data when this may compromise learning more about their efficacy? And might widespread deployment of first generation Covid-19 vaccines make it harder to properly trial vaccines at earlier stages of development but which may have the potential to be more effective? Claudia Hammond discusses the dilemmas with Dr Gregory Poland, director of the Mayo Vaccine Research Group.

People who are double-jointed are much more prone to suffering from anxiety and panics attacks. Reporter Madeleine Finlay investigates the link.

Claudia consults mental health experts for tips to help people get through the coming months of uncertainty and anxiety.

Boston University epidemiologist Matthew Fox joins Claudia with insights on vaccine hesitancy, how Namibia is maintaining its HIV treatment services under Covid-19 restrictions and whether antibiotics can prevent surgery for appendicitis.

Presenter: Claudia Hammond Producer: Andrew Luck-Baker

(Picture: A doctor preparing a coronavirus vaccine. Photo credit: Filippo Bacci/Getty Images.)

More Episodes

Jun 24, 2026
Lack of evidence most IVF ‘add-ons’ improve fertility

Many people with infertility use in vitro fertilisation (IVF), however the probability of having a baby following IVF is only approximately 30-40% per cycle and decreases significantly with age. It can be a lengthy and expensive process. Providers sometimes offer ‘add-ons’, additional treatments that they claim could help patients conceive, which are themselves also usually expensive. In Australia, New Zealand and the United Kingdom more than 70% of patients pay for at least one of these add-ons. A new review published in The Lancet Obstetrics, Gynaecology, & Women’s Health journal has found that evidence on the benefits of these add-on treatments is unclear. Claudia Hammond speaks to Dr Sarah Lensen, Senior Research Fellow in the Department of Obstetrics, Gynaecology and Newborn Health at the University of Melbourne.

Joining Claudia from Ghana is genito-urinary consultant and HIV expert, Vanessa Apea. Claudia and Vanessa discuss a draft African Charter on Family, Sovereignty and Values, which claims that comprehensive sex education, as well as a range of sexual and reproductive health rights, are a threat to African families from foreign ideologies.

They also discuss a report from the Office of Inspector General of US Agency for International Development (USAID) which reveals that President Donald Trump’s administration has spent hundreds of thousands of dollars in storage and transportation costs for $9.7 million worth of contraceptives that are being stored in Belgium rather than distributed to the various low-income countries they were intended for. Many of the withheld contraceptives are now expired or unusable due to their removal from temperature-controlled storage.

We also hear from Health Check reporter Jane Chambers in the Chilean city of Valdivia, where wetlands are part of everyday life—and increasingly, part of people’s health. And we hear how faecal-microbiome transplants could improve the efficacy of some antidepressants in patients with major depressive disorder.

Presenter: Claudia Hammond Producers: Jonathan Blackwell & Georgia Christie


26min 29sec



Covid-19 vaccines: Unknowns and dilemmas

--:--
--:--